Send us Fan Mail

What are you actually buying when you purchase a red light therapy device? In Part 3, Dr. Ginger Bowler and 40-year industry veteran David Malone examine the controversy surrounding photobiomodulation devices, testing, regulation, engineering, marketing, and product quality.

David explains how FDA clearance and third-party safety testing once shaped the industry, what he believes changed after the device category became easier to enter, and why two products that look nearly identical may perform very differently.

The conversation also examines panels versus skin-contact devices, true LED wavelengths versus colored lenses, ineffective wavelength combinations, copycat products, safety shortcuts, and the potential damage inferior devices could do to the reputation of red light therapy.

Later, Ginger and David discuss emerging interest in applying photobiomodulation to the head, including SPECT imaging, circulation, concussion and traumatic brain injury research, and cognitive health.

In this episode:

• FDA 510(k) clearance and device testing
• What changed when market entry became easier
• Why some combinations of light may not work well together
• Panels versus skin-contact pads
• Colored lenses versus true LED wavelengths
• Marketing claims and heavily promoted devices
• Engineering shortcuts and copycat products
• The debate surrounding red light therapy regulation
• Photobiomodulation and brain research
• SPECT imaging and cerebral blood flow
• Concussions, traumatic brain injuries and cognitive function

Support the show

Send us Fan Mail

Is red light alone enough? In Part 2, Dr. Ginger Bowler and 40-year light-therapy industry veteran David Malone explore why photobiomodulation devices may use combinations of red, near-infrared, blue, and green light rather than relying on a single wavelength.

David explains how combining red and infrared appeared to reduce treatment plateaus, where pulsing originated, what Nogier and Solfeggio frequencies are, how duty cycle works, and why different wavelengths penetrate the body at different depths.

They also discuss the addition of blue and green light, observations reported by practitioners and device users, Doppler testing, circulation, treatment duration, and what David has learned through decades of developing LED light-therapy systems.

In this episode:

• Why red light alone may be only part of the story
• Red and near-infrared combinations
• The discovery of infrared light
• Why treatment responses may plateau
• The origin of pulsed light therapy
• Nogier and Solfeggio frequencies
• Cymatics and frequency patterns
• Blue and green light applications
• Duty cycle explained in plain language
• How deeply different wavelengths penetrate
• How treatment duration was evaluated
• Doppler testing and circulation

Support the show

Send us Fan Mail

Not all red light therapy devices are created equal. In Part 1 of this conversation, Dr. Ginger Bowler sits down with David Malone, a light-therapy device designer and manufacturer with 40 years of industry experience, to explain what actually matters in photobiomodulation—and what may be little more than marketing.

David traces the evolution of light therapy from early helium-neon lasers and veterinary applications to modern LED pads and panels. He explains red and near-infrared wavelengths, pulsing, treatment distance, skin contact, light penetration, overlapping LED coverage, FDA clearance, UL testing, and the engineering hidden inside a device.

In this episode:

• Red light versus near-infrared light
• What wavelength numbers actually mean
• The origins of pulsed light therapy
• Lasers versus LEDs
• Skin-contact pads versus stand-alone panels
• Why distance from the skin matters
• True wavelengths versus colored plastic lenses
• FDA 510(k) clearance and device testing
• The danger of copying a device without understanding its engineering
• The half-cent component that prevented a serious device failure

Support the show